Low Serum Hepatitis B Surface Antigen Level Predicts Compensated Cirrhosis Caused by Chronic Hepatitis B in HBeAg Positive Patients in East China
- PMID: 26322110
- PMCID: PMC4546813
- DOI: 10.5812/hepatmon.29183
Low Serum Hepatitis B Surface Antigen Level Predicts Compensated Cirrhosis Caused by Chronic Hepatitis B in HBeAg Positive Patients in East China
Abstract
Backgrounds: Serum hepatitis B surface antigen (HBsAg) levels are associated with fibrosis in patients with chronic hepatitis B (CHB) infection.
Objectives: The aim of our study was to evaluate serum HBsAg level as a biomarker for compensated cirrhosis in hepatitis B e antigen (HBeAg) positive CHB patients.
Patients and methods: Two-hundred and one HBeAg-positive Chinese CHB patients with or without cirrhosis were enrolled in this retrospective study. Cirrhosis was diagnosed based on liver biopsy. Furthermore, patients with decompensated cirrhosis were excluded. A statistical analysis was performed regarding the association between serum HBsAg level and compensated cirrhosis.
Results: Patients with compensated cirrhosis had a significantly lower mean serum HBsAg level compared to those without cirrhosis (3.27 Log10 IU/mL VS 4.17 Log10 IU/mL, P < 0.001). Furthermore, examining the correlation with compensated cirrhosis revealed that lower level of serum HBsAg was a significant factor in multivariate analysis. The area under the receiver operating characteristics curve of serum HBsAg was 0.856 for compensated cirrhosis. A positive predictive value of 66.2% and negative predictive value of 90.7% were obtained with a cut-off value of < 3.60 Log10 IU/mL (4000 IU/mL) of serum HBsAg. Moreover, the rate of compensated cirrhosis increased to 75.0% after combining with APRI > 2.
Conclusions: In HBeAg positive CHB patients, low serum HBsAg level is a useful predictor of compensated cirrhosis.
Keywords: Chronic; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B e Antigens; Liver Cirrhosis.
Figures





Similar articles
-
Hepatitis B surface antigen quantification at hepatitis B e antigen seroconversion predicts virological relapse after the cessation of entecavir treatment in hepatitis B e antigen-positive patients.Int J Infect Dis. 2016 Feb;43:43-48. doi: 10.1016/j.ijid.2015.10.019. Epub 2015 Oct 30. Int J Infect Dis. 2016. PMID: 26523639
-
Association of Coexistent Hepatitis B Surface Antigen and Antibody With Severe Liver Fibrosis and Cirrhosis in Treatment-Naive Patients With Chronic Hepatitis B.JAMA Netw Open. 2022 Jun 1;5(6):e2216485. doi: 10.1001/jamanetworkopen.2022.16485. JAMA Netw Open. 2022. PMID: 35696167 Free PMC article.
-
[Relationship between hepatitis B surface antigen, HBV DNA quantity and liver fibrosis severity].Zhonghua Gan Zang Bing Za Zhi. 2015 Apr;23(4):254-7. doi: 10.3760/cma.j.issn.1007-3418.2015.04.005. Zhonghua Gan Zang Bing Za Zhi. 2015. PMID: 26133815 Chinese.
-
Treatment of chronic hepatitis B: case selection and duration of therapy.J Gastroenterol Hepatol. 2002 Apr;17(4):409-14. doi: 10.1046/j.1440-1746.2002.02767.x. J Gastroenterol Hepatol. 2002. PMID: 11982721 Review.
-
Chronic hepatitis B virus infection in Asian countries.J Gastroenterol Hepatol. 2000 Dec;15(12):1356-61. doi: 10.1046/j.1440-1746.2000.0150121356.x. J Gastroenterol Hepatol. 2000. PMID: 11197043 Review.
Cited by
-
Analysis of S gene characteristic sequences and changes in properties of protein expression in HBV ASCs with low-level HBsAg.Front Med (Lausanne). 2022 Sep 14;9:948842. doi: 10.3389/fmed.2022.948842. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36186824 Free PMC article.
-
Comparing HBV Viral Load in Serum, Cerumen, and Saliva and Correlation With HBeAg Serum Status in Patients With Chronic Hepatitis B Infection.Hepat Mon. 2016 Apr 27;16(5):e30385. doi: 10.5812/hepatmon.30385. eCollection 2016 May. Hepat Mon. 2016. PMID: 27313632 Free PMC article.
-
Hepatocellular Carcinoma and Its Precursors in 103 HBV-Related Cirrhotic Explanted Livers: A Study from South Iran.Hepat Mon. 2016 Jul 20;16(8):e38584. doi: 10.5812/hepatmon.38584. eCollection 2016 Aug. Hepat Mon. 2016. PMID: 27795725 Free PMC article.
-
Serum hepatitis B surface antigen levels predict insignificant fibrosis and non-cirrhosis in hepatitis B e antigen positive patients with normal or mildly elevated alanine transaminase levels.Oncotarget. 2017 Sep 23;8(49):86463-86470. doi: 10.18632/oncotarget.21210. eCollection 2017 Oct 17. Oncotarget. 2017. PMID: 29156808 Free PMC article.
-
Effect of entecavir in the treatment of patients with hepatitis B virus-related compensated and decompensated cirrhosis.Exp Ther Med. 2017 Oct;14(4):3908-3914. doi: 10.3892/etm.2017.4963. Epub 2017 Aug 18. Exp Ther Med. 2017. PMID: 29043000 Free PMC article.
References
-
- Butterworth RF. Complications of cirrhosis III. Hepatic encephalopathy. J Hepatol. 2000;32(1 Suppl):171–80. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources